A Curve‐Free Method for Phase I Clinical Trials
暂无分享,去创建一个
[1] J O'Quigley,et al. Continual reassessment method: a practical design for phase 1 clinical trials in cancer. , 1990, Biometrics.
[2] S. Goodman,et al. Some practical improvements in the continual reassessment method for phase I studies. , 1995, Statistics in medicine.
[3] K. Doksum. Tailfree and Neutral Random Probabilities and Their Posterior Distributions , 1974 .
[4] Jen Tang,et al. On the distribution of the product of independent beta random variables , 1984 .
[5] L V Rubinstein,et al. A comparison of two phase I trial designs. , 1994, Statistics in medicine.
[6] D. Fan. The distribution of the product of independent beta variables , 1991 .
[7] J. Berger. Statistical Decision Theory and Bayesian Analysis , 1988 .
[8] J. Whitehead,et al. Bayesian decision procedures with application to dose-finding studies , 1997 .
[9] S. Walker,et al. A bayesian nonparametric approach to determining a maximum tolerated dose , 1997 .
[10] D. Faries,et al. Practical modifications of the continual reassessment method for phase I cancer clinical trials. , 1994, Journal of biopharmaceutical statistics.
[11] J O'Quigley,et al. Continual reassessment method: a likelihood approach. , 1996, Biometrics.